Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+2.01%
1,051.07
+20.67
+2.01%
1,030.401,038.581,051.561,035.31
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
583.25
+1.70
+0.29%
581.55581.55588.95580.07
SIXE
Energy
SIXE
Energy
SIXE
-0.41%
1,275.21
-5.30
-0.41%
1,280.511,276.071,284.111,270.93
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,666.11
+11.22
+0.68%
1,654.891,661.281,676.931,658.69
SIXM
Financials
SIXM
Financials
SIXM
+0.11%
608.86
+0.65
+0.11%
608.21610.01616.39604.82
SIXR
Staples
SIXR
Staples
SIXR
+0.45%
825.13
+3.69
+0.45%
821.44825.11826.13814.89
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.05%
198.30
-0.090
-0.05%
198.39198.39199.86197.46
SIXT
Technology
SIXT
Technology
SIXT
+0.45%
2,756.00
+12.41
+0.45%
2,743.592,763.922,779.962,746.33
SIXU
Utilities
SIXU
Utilities
SIXU
+0.30%
916.95
+2.77
+0.30%
914.18917.51924.94916.49
SIXV
Health care
SIXV
Health care
SIXV
+0.98%
1,479.75
+14.36
+0.98%
1,465.391,470.631,483.871,470.63
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.97%
2,239.08
+21.42
+0.97%
2,217.662,241.932,262.302,226.34
MDMA:CNSX
Pharmala Biotech Holdings Inc
CA$0.11
0.00%
(0.00) 1D
Mar 25, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
CA$0.11
High
CA$0.11
Low
CA$0.11
Mkt. cap
11.95M
Avg. vol.
76.74K
Volume
1.59K
52-wk high
CA$0.19
52-wk low
CA$0.08
EPS
-CA$0.02
News stories
From sources across the web
About Pharmala Biotech Holdings Inc
CEO-
Employees-
Founded2021
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Last report
Apr 29, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -CAD
Revenue / Estimate
206.44K/ (- est.)CAD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Feb 2025
May 2025
Aug 2025
Nov 2025
Revenue
145.66K
135.17K
267.38K
206.44K
Cost of goods sold
9.50K
9.62K
34.04K
34.84K
Cost of revenue
9.50K
9.62K
34.04K
34.84K
Research and development expenses
89.43K
76.34K
44.91K
41.10K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
355.05K
310.04K
404.68K
320.96K
Operating expense
914.04K
614.14K
553.47K
498.41K
Total operating expenses
923.54K
623.76K
587.50K
533.25K
Operating income
-777.89K
-488.59K
-320.13K
-326.81K
Other non operating income
-15.85K
-35.65K
-41.00K
-16.84K
EBT including unusual items
-810.77K
-524.24K
-361.13K
-409.70K
EBT excluding unusual items
-810.77K
-524.24K
-361.13K
-343.65K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-810.77K
-524.24K
-361.13K
-409.70K
Net profit margin
-556.63%
-387.84%
-135.07%
-198.46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
29.12K
29.17K
29.19K
29.76K
EBITDA
-764.82K
-475.47K
-306.98K
-313.10K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more